No-Antibiotics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
No-Antibiotics - overview
Established
2017
Location
Qingdao, Shandong, China
Primary Industry
Biotechnology
About
Established in 2017 and based in Qingdao, China, No-Antibiotics is a provider of integrated solutions for phage resistant bacteria, currently serving the animal, fruit and vegetable, and human health sectors. At the same time, the company is the head company of alternative resistance solutions in the domestic animal protection field, and has established the largest enterprise-level phage library in China. The company's R&D team has 26 masters, 7 PhDs and 6 contracted special experts, and has established long-term cooperation with Beijing University of Chemical Technology, China Ocean University and other institutions. As of August 2022, the company has obtained 21 invention patents and 78 bacteriophage strain preservation certificates.
The company mainly develops phage preparations, targeting bacteria with high morbidity and serious drug resistance that cause animal sickness in agriculture and animal husbandry, including Staphylococcus, Salmonella, etc. The company's products are divided into animal, aquatic, pet and feed additives segments, specifically Noanso Clear, Noansa, etc.
Current Investors
Hyfinity Investments, Milestone Capital, Qingsong Fund
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.phageseeker.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.